J B Chemicals and Pharmaceuticals Ltd
NSE:JBCHEPHARM

Watchlist Manager
J B Chemicals and Pharmaceuticals Ltd Logo
J B Chemicals and Pharmaceuticals Ltd
NSE:JBCHEPHARM
Watchlist
Price: 1 743.4 INR 1.95% Market Closed
Market Cap: 270.8B INR
Have any thoughts about
J B Chemicals and Pharmaceuticals Ltd?
Write Note

Net Margin
J B Chemicals and Pharmaceuticals Ltd

16.3%
Current
16%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
16.3%
=
Net Income
5.9B
/
Revenue
35.9B

Net Margin Across Competitors

Country IN
Market Cap 270.6B INR
Net Margin
16%
Country JP
Market Cap 776 550.9T JPY
Net Margin
-79%
Country US
Market Cap 710.5B USD
Net Margin
20%
Country UK
Market Cap 440.4B GBP
Net Margin
-4%
Country DK
Market Cap 3.3T DKK
Net Margin
35%
Country US
Market Cap 373.5B USD
Net Margin
17%
Country US
Market Cap 251.1B USD
Net Margin
19%
Country CH
Market Cap 202.7B CHF
Net Margin
20%
Country CH
Market Cap 183.3B CHF
Net Margin
35%
Country UK
Market Cap 162.4B GBP
Net Margin
13%
Country IE
Market Cap 146B USD
Net Margin
-126%
No Stocks Found

J B Chemicals and Pharmaceuticals Ltd
Glance View

Market Cap
270.6B INR
Industry
Pharmaceuticals

JB Chemicals & Pharmaceuticals Ltd. is a holding company, which engages in the manufacture and trade of pharmaceutical products. The company is headquartered in Mumbai, Maharashtra and currently employs 4,340 full-time employees. B. Chemicals & Pharmaceuticals Limited is an India-based pharmaceutical company. The firm is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredients (APIs). The company is involved in the provision of product development services. The firm offers varied products and dosage forms across therapeutic categories, which includes gastroenterology, hypertension, dermatology, nephrology, respiratory, virology, diabetes, wound care, anti-infectives, pharmacovigilance and nicotine replacement therapy (NRT). Its offers lozenges, which includes center-filled, soft-centered lozenges, center-filled, powder lozenges, herbal lozenges, and medicated lozenges. Its APIs products include Diclofenac Sodium, Diclofenac Diethylamine, Diclofenac Acid, Diclofenac Potassium, Nifedipine, Atenolol, Cilnidipine, and Ciprofloxacin HCl. The firm exports its products to over 40 countries across the world.

JBCHEPHARM Intrinsic Value
1 190.38 INR
Overvaluation 32%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
16.3%
=
Net Income
5.9B
/
Revenue
35.9B
What is the Net Margin of J B Chemicals and Pharmaceuticals Ltd?

Based on J B Chemicals and Pharmaceuticals Ltd's most recent financial statements, the company has Net Margin of 16.3%.